All lobbying filings

Akin Gump Strauss Hauer & Feld

Akin Gump Strauss Hauer & Feld filed a Q2 report for Resmed Corp. on July 20, 2026, reporting $110,000 in lobbying income.

Lobbying for Resmed Corp. · Global manufacturer of medical technologies.

As filed: AKIN GUMP STRAUSS HAUER & FELD for RESMED CORP.

All filings by Akin Gump Strauss Hauer & Feld · Everything Resmed Corp. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$110,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Lobbyists on this filing 1

ANNA ABRAM New on this filing

Previously held: Dpty Comm, Pol, Leg, Intnl Affrs, FDA, Mar19Jan21; Mar17Mar19; Spcl Asst HHS, Jan21Mar17; Dec09Jan21; Hlth Dirctr, Sen Burr, Sen Hlth, L&P Comm, Apr09Dec09; Stff Mbr, Sen VA Comm, Feb09Apr09; AsstDrctr, WH Jan0709; LA, LC, SA, SenSantorum, May03Dec06

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Tariff (miscellaneous tariff bills)

Issues related to Section 232 investigation on medical devices.

Health Issues

Issues related to AI-enabled medical devices, sleep health, and the management and prevention of chronic disease.

Medicare/Medicaid

Issues related to respiratory, cloud-connected sleep care, and chronic disease prevention in the Medicare program.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.